Minnesota Oncology Hematology, PA is a clinical research site located in Minneapolis, Minnesota, United States 55404.
Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Minnesota Oncology Hematology, PA has participated in 16 clinical trials with 2 currently active.
Therapeutic areas: HER2 Positive Breast Cancer, Colorectal Neoplasms, Breast Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Puma Biotechnology, Inc., Gilead Sciences.
Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Minnesota Oncology Hematology, PA has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Minnesota Oncology Hematology, PA has 16 clinical trials on record, with 2 currently active. Their work covers HER2 Positive Breast Cancer, Colorectal Neoplasms, Breast Cancer.
Minnesota Oncology Hematology, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.